U.S. Markets closed

pSivida Corp. (PSDV)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
1.07+0.01 (+0.94%)
At close: 4:00PM EDT
People also watch
Full screen
Previous Close1.06
Bid0.70 x 300
Ask1.26 x 300
Day's Range1.03 - 1.08
52 Week Range1.03 - 4.03
Avg. Volume699,753
Market Cap42.11M
PE Ratio (TTM)-1.95
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journals2 months ago

    Watertown’s pSivida files for European approval of treatment to prevent blindness

    After unveiling positive data last week from a late-stage trial of its experimental, long-acting treatment for a leading cause of blindness, Watertown-based pSivida said Thursday that it has filed for approval in Europe. The 21-employee company (PSDV) said it had submitted an application to market its product, Durasert, in the European Union. It’s a major milestone for pSivida following a turbulent 2016 in which the company’s stock price fell precipitously and it got a new CEO.

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of PSDV earnings conference call or presentation 4-May-17 8:30pm GMT

    Q3 2017 pSivida Corp Earnings Call

  • Capital Cube3 months ago

    ETFs with exposure to pSivida Corp. : May 22, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to pSivida Corp. Here are 5 ETFs with the largest exposure to PSDV-US. Comparing the performance and risk of pSivida Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)